Justus Adamson

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 23(Granted Patents)

Location History:

Durham, NC (US) (2019 - 2024)
Durham Durham, NC (US) (2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12226483 - Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use (2025-02-18),

2. 11992697 - X-ray psoralen activated cancer therapy (X-PACT) (2024-05-28),

3. 11865359 - Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties (2024-01-09),

4. 11786595 - Methods for radiotherapy to trigger light activation drugs (2023-10-17),

5. 11577092 - Phosphor-containing drug activator activatable by a monte carlo derived X-ray exposure, system containing the activator, and methods for use (2023-02-14),

6. 11376445 - Systems and methods for single isocenter radiotherapy of multiple targets (2022-07-05),

7. 11305131 - X-ray psoralen activated cancer therapy (X-PACT) (2022-04-19),

8. 11260129 - Phosphor-containing drug activator, suspension thereof, system containing the suspension, and methods for use (2022-03-01),

9. 11207409 - X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments (2021-12-28),

10. 11135294 - Methods for radiotherapy to trigger light activation drugs (2021-10-05),

11. 10940329 - Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use (2021-03-09),

12. 10596387 - Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties (2020-03-24),

13. 10441810 - X-ray psoralen activated cancer therapy (X-PACT) (2019-10-15),

As an assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can create a detailed article about inventor Justus Adamson. Let's start with the following structure:

Title: The Innovative Work of Justus Adamson in Cancer Therapy and Imaging

Introduction:

Justus Adamson is a prominent inventor based in Durham, NC, with a total of 12 patents to his name. His groundbreaking contributions in the field of cancer therapy and imaging have significantly impacted the medical industry.

Latest Patents:

Among his latest patents is the X-ray Psoralen Activated Cancer Therapy (X-PACT), a revolutionary method for treating diseased sites in both humans and animals. This patent involves injecting phosphors capable of emitting ultraviolet or visible light into the body to target the diseased areas. Another notable invention is the Tumor Imaging with X-rays and Other High Energy Sources using photon-emitting phosphors as contrast agents with therapeutic properties.

Career Highlights:

Justus Adamson has a remarkable career history, having worked with esteemed organizations such as Duke University and Immunolight, LLC. His expertise and dedication to innovation have led to significant advancements in the medical field, particularly in the areas of cancer treatment and imaging technologies.

Collaborations:

Throughout his career, Justus Adamson has collaborated with talented individuals, including Zakaryae Fathi and Mark Oldham. These collaborations have been instrumental in the development and success of his inventions, further solidifying his reputation as a visionary inventor in the industry.

Conclusion:

In conclusion, Justus Adamson's relentless pursuit of innovation and his invaluable contributions to cancer therapy and imaging technologies have established him as a key figure in the field. His patents reflect his passion for improving medical treatments and diagnostic methods, making a lasting impact on the lives of many individuals.

This text is generated by artificial intelligence and may not be accurate.